论文部分内容阅读
目的探讨经尿道前列腺中叶并单侧叶汽化电切术(TUVRP)治疗高危重度前列腺增生(BPH)的安全性及疗效。方法回顾性分析248例高危重度BPH患者行经尿道前列腺中叶并单侧叶的TUVRP临床资料。结果本组患者均安全度过围手术期,无电切综合症、大量失血发生,排尿功能明显改善。术后随访3月～36月,国际前列腺症状评分(IPSS)由术前(28.6±3.3)分降至(9.1±2.3)分,生活质量评分(QOL)由(4.5±0.2)分降至(2.1±0.2)分,最大尿流率由(6.3±0.3)ml/s提高至(17.4±0.2)ml/s,剩余尿量由(192±13)ml降至(19.5±12.3)ml。结论经尿道前列腺中叶并单侧叶汽化电切术手术时间短,出血量少,安全有效,适合于高危重度BPH的治疗。
Objective To investigate the safety and efficacy of transurethral prostatectomy with unilateral leaflet electrovaporization (TUVRP) in the treatment of high-risk severe benign prostatic hyperplasia (BPH). Methods TUVRP clinical data of 248 patients with high-risk severe BPH who underwent transabdominal prostate and unilateral lobes were retrospectively analyzed. Results The patients were safely perioperative period, no cutting-off syndrome, a large number of blood loss, urinary function improved significantly. After 3 months to 36 months of follow-up, the International Prostate Symptom Score (IPSS) decreased from (28.6 ± 3.3) points to (9.1 ± 2.3) points and the quality of life score (QOL) decreased from 4.5 ± 0.2 points to 2.1 ± 0.2). The maximum urinary flow rate increased from (6.3 ± 0.3) ml / s to (17.4 ± 0.2) ml / s and the residual urine volume decreased from (192 ± 13) ml to (19.5 ± 12.3) ml. Conclusions The transurethral prostate with unilateral leaflet electrovaporization has short operative time, less bleeding, safe and effective, and is suitable for the treatment of high-risk severe BPH.